AbbVie Inc. (ABBV)
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
Nvidia's high valuation could make the stock vulnerable to a sell-off if the company fall short of expectations. AbbVie is a top healthcare company with underrated growth prospects.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
AbbVie offers a high dividend yield and a great track record of dividend increases. Lowe's Companies is a Dividend King poised to benefit from the aging of U.S. homes.
High Yields And Low Multiples - 3 Of My Favorite Dividend Stocks To Buy Right Now
JPMorgan CEO Jamie Dimon expressed concern about inflation and predicts higher interest rates for longer than expected. He highlighted secular drivers such as the energy transition, geopolitical issues, infrastructure spending, and large deficits/debt levels. The favorable period for inflation in developed nations from 2009 to 2021 is likely over.
3 Biotech Stocks to Buy on the Dip: May 2024
Biotech is one of the most exciting industries to invest in right now. Companies have drugs on the market worth billions and continue to strive to produce the newest and best treatments in modern medicine.
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
A Must-Own Stock for Any Portfolio
This company offers growth, high yield, and dividend growth.
2 Billion More Reasons to Buy AbbVie Stock
AbbVie is bolstering its psychiatry pipeline with an acquisition. The biotech it's acquiring is developing psychedelic-adjacent drugs.
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
Since 1928, there have been 25 bear markets, or declines in the S&P 500 of 20% or more, according to Yardeni Research. Market corrections have been far more common.
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
AbbVie's lead drug Humira lost its patent-protected market exclusivity in the U.S. last year. Despite shrinking Humira revenues, AbbVie's first-quarter sales grew thanks to more recently launched blockbusters.
7 Value Stocks to Buy and Hold for a Decade of Dominance
Finding equities with the potential for steady, long-term development is crucial. These seven prospects span a variety of industries and offer solid arguments for long-term investment.
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?
